Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Zenshiro Tamaki, Yoshihide Asano, Masaru Hatano, Atsushi Yao, Tomohiko Kawashima, Manabu Tomita, Koichiro Kinugawa, Ryozo Nagai & Shinichi Sato. (2012) Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases. Modern Rheumatology 22:1, pages 94-99.
Read now
Read now
Peter Kovacic. (2011) Novel electrostatic mechanism for mode of action by N-acetylated proteins: cell signaling and phosphorylation. Journal of Receptors and Signal Transduction 31:3, pages 193-198.
Read now
Read now
Articles from other publishers (50)
Elena V. Mikhailova, Irina V. Romanova, Alexei Y. Bagrov & Natalia I. Agalakova. (2023) Fli1 and Tissue Fibrosis in Various Diseases. International Journal of Molecular Sciences 24:3, pages 1881.
Crossref
Crossref
Gloria Pedot, Joana Graça Marques, Philip P. Ambühl, Marco Wachtel, Stephanie Kasper, Quy A. Ngo, Felix K. Niggli & Beat W. Schäfer. (2022) RETRACTED: Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization. Neoplasia 27, pages 100784.
Crossref
Crossref
Yulia N. Grigorova, Ondrej Juhasz, Jeffrey M. Long, Valentina I. Zernetkina, Mikayla L. Hall, Wen Wei, Christopher H. Morrell, Natalia Petrashevskaya, Audrey Morrow, Katherine H. LaNasa, Alexei Y. Bagrov, Peter R. Rapp, Edward G. Lakatta & Olga V. Fedorova. (2022) Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats. International Journal of Molecular Sciences 23:9, pages 4563.
Crossref
Crossref
Ching-Tse Ting & Bor-Sen Chen. (2022) Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications. International Journal of Molecular Sciences 23:7, pages 3649.
Crossref
Crossref
Xuan Wang, Mara Lennard Richard, Pengfei Li, Brittany Henry, Steven Schutt, Xue-Zhong Yu, Hongkuan Fan, Weiru Zhang, Gary Gilkeson & Xian K. Zhang. (2021) Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target. The Journal of Immunology 206:1, pages 59-66.
Crossref
Crossref
Yi-Sheng He, Xiao-Ke Yang, Yu-Qian Hu, Kun Xiang & Hai-Feng Pan. (2021) Emerging role of Fli1 in autoimmune diseases. International Immunopharmacology 90, pages 107127.
Crossref
Crossref
Yongqing Zhang, Wen Wei, Victoria Shilova, Natalia N. Petrashevskaya, Valentina I. Zernetkina, Yulia N. Grigorova, Courtney A. Marshall, Rachel C. Fenner, Elin Lehrmann, William H. WoodIIIIII, Kevin G. Becker, Edward G. Lakatta, Alexei Y. Bagrov & Olga V. Fedorova. (2019) Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt‐Sensitive Hypertension. Journal of the American Heart Association 8:20.
Crossref
Crossref
Nao Nagai, Hiroto Ohguchi, Ryo Nakaki, Yoshihiro Matsumura, Yasuharu Kanki, Juro Sakai, Hiroyuki Aburatani & Takashi Minami. (2018) Downregulation of ERG and FLI1 expression in endothelial cells triggers endothelial-to-mesenchymal transition. PLOS Genetics 14:11, pages e1007826.
Crossref
Crossref
Takuya Miyagawa, Yohei Ichimura, Kouki Nakamura, Megumi Hirabayashi, Takashi Yamashita, Ryosuke Saigusa, Shunsuke Miura, Takehiro Takahashi, Tetsuo Toyama, Takashi Taniguchi, Kaname Akamata, Ayumi Yoshizaki, Shinichi Sato & Yoshihide Asano. (2018) Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma. Journal of Dermatological Science 92:2, pages 207-214.
Crossref
Crossref
Yoshihide Asano. (2018)
What can we learn from
Fli1
-deficient mice, new animal models of systemic sclerosis?
. Journal of Scleroderma and Related Disorders 3:1, pages 6-13.
Crossref
Crossref
Lukasz Stawski, Grace Marden & Maria Trojanowska. (2018) The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway. The Journal of Immunology 200:1, pages 248-259.
Crossref
Crossref
Maria Trojanowska & John Varga. 2017. Scleroderma. Scleroderma
261
280
.
Hsiao-Mei ChenChuen-Mao YangJia-Feng Chang, Chi-Sheng WuKee-Chin SiaWei-Ning Lin. (2016)
AdipoR-increased intracellular ROS promotes cPLA
2
and COX-2 expressions via activation of PKC and p300 in adiponectin-stimulated human alveolar type II cells
. American Journal of Physiology-Lung Cellular and Molecular Physiology 311:2, pages L255-L269.
Crossref
Crossref
Sylvain Carras, Alexandre Valayer, Claudine Moratal, Michèle Weiss-Gayet, Gilles Pages, Francois Morlé, Guy Mouchiroud & Stéphanie Gobert. (2016) Instructive role of M-CSF on commitment of bipotent myeloid cells involves ERK-dependent positive and negative signaling. Journal of Leukocyte Biology 99:2, pages 311-319.
Crossref
Crossref
Yoshihide Asano. (2016) Recent advances in animal models of systemic sclerosis. The Journal of Dermatology 43:1, pages 19-28.
Crossref
Crossref
Yoshihide Asano. 2016. Systemic Sclerosis. Systemic Sclerosis
187
209
.
Sei-ichiro Motegi. 2016. Systemic Sclerosis. Systemic Sclerosis
155
171
.
Nichola H. Cooper, Jeya P. Balachandra & Matthew J. Hardman. (2015) Global Gene Expression Analysis in PKCα −/− Mouse Skin Reveals Structural Changes in the Dermis and Defective Wound Granulation Tissue. Journal of Investigative Dermatology 135:12, pages 3173-3182.
Crossref
Crossref
Yohei Ichimura, Yoshihide Asano, Kaname Akamata, Shinji Noda, Takashi Taniguchi, Takehiro Takahashi, Tetsuo Toyama, Yayoi Tada, Makoto Sugaya, Shinichi Sato & Takafumi Kadono. (2015) Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis. Arthritis & Rheumatology 67:12, pages 3245-3255.
Crossref
Crossref
Yoshihide Asano. (2015) Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis. The International Journal of Biochemistry & Cell Biology 67, pages 86-91.
Crossref
Crossref
Yoshihide Asano. (2015) Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features. Medical Molecular Morphology 48:3, pages 123-128.
Crossref
Crossref
Yoshihide Asano & Shinichi Sato. (2015) Vasculopathy in scleroderma. Seminars in Immunopathology 37:5, pages 489-500.
Crossref
Crossref
Kaname Akamata, Yoshihide Asano, Takashi Yamashita, Shinji Noda, Takashi Taniguchi, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Maria Trojanowska & Shinichi Sato. (2015) Endothelin Receptor Blockade Ameliorates Vascular Fragility in Endothelial Cell-Specific Fli-1-Knockout Mice by Increasing Fli-1 DNA Binding Ability. Arthritis & Rheumatology 67:5, pages 1335-1344.
Crossref
Crossref
Yannick Allanore, Robert Simms, Oliver Distler, Maria Trojanowska, Janet Pope, Christopher P. Denton & John Varga. (2015) Systemic sclerosis. Nature Reviews Disease Primers 1:1.
Crossref
Crossref
Y Li, H Luo, T Liu, E Zacksenhaus & Y Ben-David. (2014) The ets transcription factor Fli-1 in development, cancer and disease. Oncogene 34:16, pages 2022-2031.
Crossref
Crossref
Mirko Manetti. (2015) Fli1 deficiency and beyond: a unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis. Experimental Dermatology 24:4, pages 256-257.
Crossref
Crossref
Takashi Taniguchi, Yoshihide Asano, Kaname Akamata, Shinji Noda, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Maria Trojanowska & Shinichi Sato. (2015) Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin‐Treated Fli‐1–Haploinsufficient Mice. Arthritis & Rheumatology 67:2, pages 517-526.
Crossref
Crossref
Shinji Noda, Yoshihide Asano, Satoshi Nishimura, Takashi Taniguchi, Katsuhito Fujiu, Ichiro Manabe, Kouki Nakamura, Takashi Yamashita, Ryosuke Saigusa, Kaname Akamata, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Daisuke Tsuruta, Maria Trojanowska, Ryozo Nagai & Shinichi Sato. (2014) Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nature Communications 5:1.
Crossref
Crossref
Hideo Kudo, Masatoshi Jinnin, Yoshihide Asano, Maria Trojanowska, Wakana Nakayama, Kuniko Inoue, Noritoshi Honda, Ikko Kajihara, Katsunari Makino, Satoshi Fukushima & Hironobu Ihn. (2014) Decreased Interleukin-20 Expression in Scleroderma Skin Contributes to Cutaneous Fibrosis. Arthritis & Rheumatology 66:6, pages 1636-1647.
Crossref
Crossref
Yoshihide ASANO. (2014) A unifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 – the development of a new animal model of systemic sclerosis –. Japanese Journal of Clinical Immunology 37:6, pages 475-487.
Crossref
Crossref
Kaname Akamata, Yoshihide Asano, Naohiko Aozasa, Shinji Noda, Takashi Taniguchi, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama & Shinichi Sato. (2014) Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1. Arthritis Research & Therapy 16:2, pages R86.
Crossref
Crossref
Yoshihide Asano & Shinichi Sato. (2013) Animal Models of Scleroderma: Current State and Recent Development. Current Rheumatology Reports 15:12.
Crossref
Crossref
Yoshihide Asano & Maria Trojanowska. (2013) Fli1 Represses Transcription of the Human α2(I) Collagen Gene by Recruitment of the HDAC1/p300 Complex. PLoS ONE 8:9, pages e74930.
Crossref
Crossref
S. Noda, Y. Asano, T. Takahashi, K. Akamata, N. Aozasa, T. Taniguchi, Y. Ichimura, T. Toyama, H. Sumida, Y. Kuwano, K. Yanaba, Y. Tada, M. Sugaya, T. Kadono & S. Sato. (2013) Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis. Rheumatology 52:5, pages 790-799.
Crossref
Crossref
Victoria J. Findlay, Amanda C. LaRue, David P. Turner, Patricia M. Watson & Dennis K. Watson. 2013.
1
61
.
Y. Asano. 2013. Brenner's Encyclopedia of Genetics. Brenner's Encyclopedia of Genetics
64
66
.
S. Noda, Y. Asano, K. Akamata, N. Aozasa, T. Taniguchi, T. Takahashi, Y. Ichimura, T. Toyama, H. Sumida, K. Yanaba, Y. Tada, M. Sugaya, T. Kadono & S. Sato. (2012) Constitutive activation of c-Abl/protein kinase C-δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma. British Journal of Dermatology 167:5, pages 1098-1105.
Crossref
Crossref
Michael Ginsberg, Daylon James, Bi-Sen Ding, Daniel Nolan, Fuqiang Geng, Jason M. Butler, William Schachterle, Venkat R. Pulijaal, Susan Mathew, Stephen T. Chasen, Jenny Xiang, Zev Rosenwaks, Koji Shido, Olivier Elemento, Sina Y. Rabbany & Shahin Rafii. (2012) Efficient Direct Reprogramming of Mature Amniotic Cells into Endothelial Cells by ETS Factors and TGFβ Suppression. Cell 151:3, pages 559-575.
Crossref
Crossref
Shinji Noda, Yoshihide Asano, Kaname Akamata, Naohiko Aozasa, Takashi Taniguchi, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Hayakazu Sumida, Koichi Yanaba, Yayoi Tada, Makoto Sugaya, Takafumi Kadono & Shinichi Sato. (2012) A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis. PLoS ONE 7:2, pages e32272.
Crossref
Crossref
Y-J Li, X Zhao, L M Vecchiarelli-Federico, Y Li, A Datti, Y Cheng & Y Ben-David. (2012) Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer Journal 2:1, pages e54-e54.
Crossref
Crossref
Steven M. Kornblau, Yi Hua Qiu, Nianxiang ZhangNeera Singh, Stefan Faderl, Alessandra Ferrajoli, Heather York, Amina A. Qutub, Kevin R. CoombesDennis K. Watson. (2011) Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood 118:20, pages 5604-5612.
Crossref
Crossref
Sashidhar S. Nakerakanti, Andreea M. Bujor & Maria Trojanowska. (2011) CCN2 Is Required for the TGF-β Induced Activation of Smad1 - Erk1/2 Signaling Network. PLoS ONE 6:7, pages e21911.
Crossref
Crossref
Tomoyasu Hattori, Lukasz Stawski, Sashidhar S. Nakerakanti & Maria Trojanowska. (2011) Fli1 Is a Negative Regulator of Estrogen Receptor α in Dermal Fibroblasts. Journal of Investigative Dermatology 131:7, pages 1469-1476.
Crossref
Crossref
Andreea M. Bujor, Yoshihide Asano, Paul Haines, Robert Lafyatis & Maria Trojanowska. (2011) The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts. Arthritis & Rheumatism 63:6, pages 1729-1737.
Crossref
Crossref
Rui Zhang, Mei Han, Bin Zheng, Ying-jie Li, Ya-nan Shu & Jin-kun Wen. (2010) Krüppel-like factor 4 interacts with p300 to activate mitofusin 2 gene expression induced by all-trans retinoic acid in VSMCs. Acta Pharmacologica Sinica 31:10, pages 1293-1302.
Crossref
Crossref
Yoshihide Asano, Andreea M. Bujor & Maria Trojanowska. (2010) The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis. Journal of Dermatological Science 59:3, pages 153-162.
Crossref
Crossref
Yoshihide ASANO. (2010) Future treatments in systemic sclerosis. The Journal of Dermatology 37:1, pages 54-70.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Allergy & Clinical Immunology 9:6, pages 574-578.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Rheumatology 21:6, pages 656-665.
Crossref
Crossref
Maria Trojanowska. (2009) Noncanonical transforming growth factor β signaling in scleroderma fibrosis. Current Opinion in Rheumatology 21:6, pages 623-629.
Crossref
Crossref